Dr. Lazarre is responsible for advancing strategic pharmacy objectives across Yale New Haven Health, overseeing pharmaceutical safety, quality, regulatory compliance and fiscal performance for all pharmacy business lines. She is active nationally, with appointments to the American Hospital Association’s committee on clinical leadership, the Connecticut Hospital Association 340B subcommittee, the 340B Health executive board and Vizient’s pharmacy advocacy council, which she chairs. Dr. Lazarre pursued pharmacy to help patients and families understand and advocate for their medication therapies, motivated in part by her sister’s and daughter’s diagnoses of Type 1 diabetes. She serves as a board member for the Greater Connecticut and Western Massachusetts chapter of Breakthrough T1D, and is on the organization’s international finance and investment committee. In December 2025, she was named a gubernatorial appointee to Connecticut’s advisory council on pharmaceutical procurement. Dr. Lazarre previously served as director of pharmacy at Mount Washington Pediatric Hospital in Baltimore, and as system director and associate chief pharmacy officer at Yale New Haven.
